<DOC>
	<DOCNO>NCT02123381</DOCNO>
	<brief_summary>This study aim investigate Changes tumor tissue serum biomarkers cetuximab combine preoperative radiotherapy locally advance thoracic middle-lower segment esophageal squamous cell carcinoma.We want find one effective biomarkers predict evaluate patient benefit cetuximab combine preoperative radiotherapy .</brief_summary>
	<brief_title>Changes Tumor Tissue Serum Biomarkers Before After Cetuximab Combined With Preoperative Radiotherapy Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>( 1 ) 18 65 year old , male female ( 2 ) Pathologically cytologically proven thoracic middlelower esophageal squamous cell carcinoma ; ( 3 ) clinical stage II stage III ; ( 4 ) Primary tumor measure ; ( 5 ) Karnofsky score &gt; 70 ; ( 6 ) Estimated life expectancy least 12 week ; ( 7 ) reproductive age woman ensure enter study period contraception ; ( 8 ) Hemoglobin≥90.0g/dL , white blood cell count（WBC）≥ 4000 cells/mm³ , Platelet count≥100,000 cells/mm³ ; ( 9 ) Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 2.5 time upper limit normal , bilirubin normal ; ( 10 ) Creatinine normal OR creatinine clearance ≥ 60 mL/min ; ( 11 ) Patients good compliance treatment followup acceptance ; ( 12 ) Forced expiratory volume one second（FEV1） ≥ 1.5 litre ≥ 75 % reference value ; ( 13 ) Considered operable ( i.e . appropriate organ function ability undergo general anesthesia ) ; ( 14 ) No severe uncontrolled cardiovascular disease ; ( 15 ) No active uncontrolled infection ; 1 . Patient distant metastasis 2 . The primary tumor lymph node already receive surgical treatment ( except biopsy ) ; 3 . Patient receive radiotherapy primary tumor lymph node ; 4 . Patient receive epidermal growth factor target therapy ; 5 . Patient receive chemotherapy immunotherapy ; 6 . Patient suffer malignant tumor ; 7 . Epidermal growth factor receptor（EGFR）mutation（） ; 8 . Patient take drug test within 1 month ; 9 . Pregnant woman Lactating Women Women productive age refuse take contraception observation period ; 10 . Subject severe allergic history idiosyncratic ; 11 . Subject severe pulmonary cardiopathic disease history ; Refuse incapable sign inform consent form participate trial ; 12 . Drug abuse alcohol addict ; 13 . Subject Personality psychiatric disease , people legal ; capacity people limited capacity civil conduct ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>tumor tissue serum biomarkers</keyword>
	<keyword>cetuximab</keyword>
	<keyword>preoperative radiotherapy</keyword>
	<keyword>esophageal squamous cell carcinoma</keyword>
</DOC>